| 000 | 01909 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517164541.0 | ||
| 264 | 0 | _c20170911 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2017.05.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMassard, Christophe | |
| 245 | 0 | 0 |
_aRECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric study. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c09 2017 |
||
| 300 |
_a185-193 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xblood |
| 650 | 0 | 4 |
_aNeoplastic Cells, Circulating _xpathology |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aResponse Evaluation Criteria in Solid Tumors |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBorget, Isabelle | |
| 700 | 1 | _aFarace, Françoise | |
| 700 | 1 | _aAspeslagh, Sandrine | |
| 700 | 1 | _aLe Deley, Marie-Cécile | |
| 700 | 1 | _aLe Tourneau, Christophe | |
| 700 | 1 | _aBidard, François-Clement | |
| 700 | 1 | _aPierga, Jean-Yves | |
| 700 | 1 | _aDieras, Veronique | |
| 700 | 1 | _aHofman, Paul | |
| 700 | 1 | _aSpano, Jean-Philippe | |
| 700 | 1 | _aFerte, Charles | |
| 700 | 1 | _aLacroix, Ludovic | |
| 700 | 1 | _aSoria, Jean-Charles | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 83 _gp. 185-193 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2017.05.016 _zAvailable from publisher's website |
| 999 |
_c27401890 _d27401890 |
||